ENDPOINTS

Novo marks sixth cardiometabolic deal of the year with Deep Apple Therapeutics

Novo Nordisk has been on a dealmaking spree this year to assuage concerns about the future of its obesity and cardiometabolic drugs. The Danish drugmaker's latest partner of choice is Apple Tree ...

Jun 11, 2025 - 12:10
 0
Novo marks sixth cardiometabolic deal of the year with Deep Apple Therapeutics
Novo Nordisk has been on a dealmaking spree this year to assuage concerns about the future of its obesity and cardiometabolic drugs. The Danish drugmaker's latest partner of choice is Apple Tree ...
Read More

Tags:

Previous Article

In photographs, scientists revel in the world they seek to discover

Next Article

V-Racer Hoverbike Is Speeding Onto Quest This Month

Related Posts

FDA's Vinay Prasad says he will 'rapidly' push forward rare disease advances

FDA's Vinay Prasad says he will 'rapidly' push forward ...

Jun 3, 2025  0

FDA adcomm narrowly votes against UroGen’s bladder cancer drug

FDA adcomm narrowly votes against UroGen’s bladder canc...

May 21, 2025  0

GSK to pay $1.2B upfront to snag Boston Pharma’s mid-stage MASH hope

GSK to pay $1.2B upfront to snag Boston Pharma’s mid-st...

May 14, 2025  0